BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1419 related articles for article (PubMed ID: 12875979)

  • 41. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
    Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R
    Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
    Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
    J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers.
    Koopman R; Zorenc AH; Gransier RJ; Cameron-Smith D; van Loon LJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1245-52. PubMed ID: 16434552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
    Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
    Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
    Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
    Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
    J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.
    Brion JP; Hanger DP; Bruce MT; Couck AM; Flament-Durand J; Anderton BH
    Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):127-33. PubMed ID: 1899184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct.
    Strong C; Anderton BH; Perry RH; Perry EK; Ince PG; Lovestone S
    Alzheimer Dis Assoc Disord; 1995; 9(4):218-22. PubMed ID: 8749611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of neurofibrillary degeneration in Alzheimer's disease.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Singh TJ; Grundke-Iqbal I
    Mol Neurobiol; 1994; 9(1-3):119-23. PubMed ID: 7888088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
    Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
    Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
    Ferrer I
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cortical load of PHF-tau in Alzheimer's disease is correlated to cholinergic dysfunction.
    Arendt T; Holzer M; Gertz HJ; Brückner MK
    J Neural Transm (Vienna); 1999; 106(5-6):513-23. PubMed ID: 10443554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.